MicroPort: Endovastec 2025 Revenue Advances 12%, Net Profit to Equity Owners Rises 12.19%

Bulletin Express

Mar 30

Shanghai MicroPort Endovascular MedTech (Endovastec), 40.32%-owned by MicroPort, reported audited results for the twelve months ended 31 December 2025, prepared under PRC accounting standards.

Revenue reached RMB1.35 billion, an 11.96% increase from 2024. Profit edged up 0.20% to RMB0.65 billion, while net profit attributable to equity owners improved 12.19% to RMB0.56 billion.

On the balance-sheet side, total assets climbed 8.15% year on year to RMB4.64 billion. Total equity attributable to equity owners rose 7.48% to RMB4.08 billion.

Management reiterated that these figures relate solely to Endovastec and do not include other MicroPort subsidiaries. Investors are advised to exercise caution when dealing in MicroPort securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/news/1166755566"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166755566\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166755566?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 23:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166755566","market":"hk","top_or_hot":-1,"title":"MicroPort: Endovastec 2025 Revenue Advances 12%, Net Profit to Equity Owners Rises 12.19%","media":"Bulletin Express","content":"<p>Shanghai MicroPort Endovascular MedTech (Endovastec), 40.32%-owned by MicroPort, reported audited results for the twelve months ended 31 December 2025, prepared under PRC accounting standards.</p>\n<p>Revenue reached RMB1.35 billion, an 11.96% increase from 2024. Profit edged up 0.20% to RMB0.65 billion, while net profit attributable to equity owners improved 12.19% to RMB0.56 billion.</p>\n<p>On the balance-sheet side, total assets climbed 8.15% year on year to RMB4.64 billion. Total equity attributable to equity owners rose 7.48% to RMB4.08 billion.</p>\n<p>Management reiterated that these figures relate solely to Endovastec and do not include other MicroPort subsidiaries. Investors are advised to exercise caution when dealing in MicroPort securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort: Endovastec 2025 Revenue Advances 12%, Net Profit to Equity Owners Rises 12.19%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort: Endovastec 2025 Revenue Advances 12%, Net Profit to Equity Owners Rises 12.19%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-30 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai MicroPort Endovascular MedTech (Endovastec), 40.32%-owned by MicroPort, reported audited results for the twelve months ended 31 December 2025, prepared under PRC accounting standards.</p>\n<p>Revenue reached RMB1.35 billion, an 11.96% increase from 2024. Profit edged up 0.20% to RMB0.65 billion, while net profit attributable to equity owners improved 12.19% to RMB0.56 billion.</p>\n<p>On the balance-sheet side, total assets climbed 8.15% year on year to RMB4.64 billion. Total equity attributable to equity owners rose 7.48% to RMB4.08 billion.</p>\n<p>Management reiterated that these figures relate solely to Endovastec and do not include other MicroPort subsidiaries. Investors are advised to exercise caution when dealing in MicroPort securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00853","symbol_name":"微创医疗","start_time":0,"source_url":"","article_id":"1166755566","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166755566","pubTimestamp":1774883325,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai MicroPort Endovascular MedTech (Endovastec), 40.32%-owned by MicroPort, reported audited results for the twelve months ended 31 December 2025, prepared under PRC accounting standards....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00853":"微创医疗"},"translate_title":"微创医疗：Endovastec 2025年收入增长12%，归属于股东的净利润增长12.19%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":1},"content_text":"Shanghai MicroPort Endovascular MedTech (Endovastec), 40.32%-owned by MicroPort, reported audited results for the twelve months ended 31 December 2025, prepared under PRC accounting standards.\nRevenue reached RMB1.35 billion, an 11.96% increase from 2024. Profit edged up 0.20% to RMB0.65 billion, while net profit attributable to equity owners improved 12.19% to RMB0.56 billion.\nOn the balance-sheet side, total assets climbed 8.15% year on year to RMB4.64 billion. Total equity attributable to equity owners rose 7.48% to RMB4.08 billion.\nManagement reiterated that these figures relate solely to Endovastec and do not include other MicroPort subsidiaries. Investors are advised to exercise caution when dealing in MicroPort securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}